Organization
Ocuphire Pharma
11 clinical trials
Clinical trial
Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision DisturbancesStatus: Completed, Estimated PCD: 2007-10-01
Clinical trial
Randomized, Placebo-Controlled, Double-Masked Study of the Safety and Efficacy of POS (0.75% Phentolamine Ophthalmic Solution) in Subjects Who Have Previously Had Keratorefractive Surgery and Have Decreased Visual Acuity Under Mesopic ConditionsStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
Randomized, Cross-Over, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution to Reverse Pharmacologically Induced Mydriasis in Normal Healthy SubjectsStatus: Completed, Estimated PCD: 2019-09-17
Clinical trial
Randomized, Parallel Arm, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Healthy SubjectsStatus: Completed, Estimated PCD: 2020-12-23
Clinical trial
Randomized, Placebo-Controlled, Double-Masked Study of the Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision DisturbancesStatus: Completed, Estimated PCD: 2022-05-19
Clinical trial
Randomized, Placebo-Controlled, Double-Masked Study of the Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular HypertensionStatus: Completed, Estimated PCD: 2019-09-11
Clinical trial
Randomized, Parallel Arm, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-03-18
Clinical trial
Randomized, Parallel Arm, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically Induced Mydriasis in Healthy Pediatric SubjectsStatus: Completed, Estimated PCD: 2022-04-18
Clinical trial
Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 3 Study of the Safety and Efficacy of Nyxol (Phentolamine Ophthalmic Solution 0.75%) as a Single Agent and With Adjunctive Low-Dose Pilocarpine Hydrochloride Ophthalmic Solution 0.4% in Subjects With PresbyopiaStatus: Completed, Estimated PCD: 2023-10-11
Clinical trial
Randomized, Placebo-Controlled, Double-Masked Study of the Safety and Efficacy of Orally Administered APX3330 in Subjects With Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy and Mild Proliferative Diabetic RetinopathyStatus: Completed, Estimated PCD: 2023-01-25
Clinical trial
Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) With Pilocarpine Eye Drops in Subjects With PresbyopiaStatus: Completed, Estimated PCD: 2021-05-17